A
$ Value
$0
Shares
46,948
Price
$0
Filed
May 19
Insider
Name
Silvestro Stephen L
Title
Chief Commercial Officer
CIK
0001773461
Roles
Officer
Transaction Details
Transaction Date
2025-05-15
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
168,262
Footnotes
Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on May 15, 2026, which is the first anniversary of the date of grant. | The stock option vests in three equal annual installments beginning May 15, 2026, the first anniversary of the grant date.
Filing Info
Silvestro Stephen L's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-12-23 | OPRX | F | $43K |
| 2025-12-19 | OPRX | M | $0 |
| 2025-12-19 | OPRX | F | $22K |
| 2025-12-19 | OPRX | M | $0 |
| 2025-10-03 | OPRX | M | $0 |
| 2025-10-03 | OPRX | ▼ | $30K |
| 2025-10-03 | OPRX | M | $0 |
| 2025-08-21 | OPRX | A | $0 |
| 2025-08-21 | OPRX | A | $0 |
| 2025-05-15 | OPRX | A | $0 |
Other Insiders at OPRX (90d)
No other insider activity at this issuer in the last 90 days.